CRK and breast adenocarcinoma: CrkII overexpression led to increased migration of rat bladder carcinoma cells [48], increased motility of fibrosarcoma [51], increased migration and invasion of Hs683 glioblastoma [50], increased migration of breast adenocarcinoma [56], and increased migration and invasion of murine hepatocarcinoma [31] cells.